PN 27: PRLN expanded its trial of PN 27.1

Paracelsian Inc. (PRLN), Ithaca, N.Y. Product: PN 27.1, a pure compound derived from an herb Indication: Cancer Status: PRLN expanded its ongoing compassionate use trial of PN 27.1 to 300 patients fro...